6-MP is commonly used in ALL chemotherapy and can induce severe ADR events in some patients (mainly myelotoxicity), which can be largely explained by TPMT variants in Caucasians and blacks but not Asians due to the low variant allele frequency [15, 29]. This evidence concerns the gene TPMT and acute lymphoblastic leukemia.